Physiologic response to pre-arrest bolus dilute epinephrine in the pediatric intensive care unit. (May 2018)

• Record Type: Journal Article
• Authors: Ross, Catherine E.; Asaro, Lisa A.; Wypij, David; Holland, Conor C.; Donnino, Michael W.; Kleinman, Monica E.
• Is Part Of: Resuscitation. Volume 126(2018)
• Page Start: 137
• Page End: 142
• Publication Date: 2018-05
• Subjects: IHCA in-hospital cardiac arrest -- ICU intensive care unit -- BDE bolus dilute epinephrine -- ECMO extracorporeal membrane oxygenation -- BCH Boston Children's Hospital -- SBP systolic blood pressure -- MAP mean arterial pressure -- DBP diastolic blood pressure -- HR heart rate; Pediatric cardiac arrest -- Acute hypotension -- Epinephrine -- Bolus-dose pressors; Resuscitation -- Periodicals; Resuscitation -- Periodicals; Réanimation -- Périodiques; Electronic journals; 616.025
• DOI: 10.1016/j.resuscitation.2018.03.011
• Languages: English
• ISSNs: 0300-9572

Abstract

Abstract: Aim: To quantify the physiologic effects of pre-arrest bolus dilute epinephrine in the pediatric intensive care unit. Methods: Patients <18 years old and ≥37 weeks gestation who received an intravenous bolus of dilute epinephrine (10 mcg/mL) in the pediatric intensive care units at our institution from January 2011 to March 2017 were retrospectively identified. Patients were excluded if doses exceeded 20 mcg/kg, or under the following circumstances: orders limiting resuscitation, extracorporeal membrane oxygenation, active chest compressions, simultaneous administration of other blood pressure-altering interventions or documented normotension prior to epinephrine. The primary outcome was change in systolic blood pressure within 5 min of epinephrine. Patients were categorized as non-responders if the change in systolic blood pressure was ≤10 mmHg. Results: One hundred forty-four patients were analyzed. The median index dose was 0.7 mcg/kg (IQR, 0.3–2.0), and the mean increase in systolic blood pressure was 31 mmHg (95% CI, 25–36; P < 0.001). Thirty-nine (27%) patients were classified as non-responders. Compared to responders, non-responders had higher rates of cardiac arrest or extracorporeal membrane oxygenation within 6 h (26% vs 10%; relative risk, 2.69; 95% CI, 1.21–5.97; P = 0.03), and had higher in-hospital mortality (51% vs 21%; relative risk, 2.45; 95% CI, 1.51–3.96; P < 0.001). Conclusions: In the majority of pre-arrest pediatric patients, bolus dilute epinephrine resulted in an increase in systolic blood pressure, and lack of blood pressure response was associated with poor outcomes. Optimal dosing of dilute epinephrine remains unclear.